Table 1 Coagulation parameters of the study patients
From: Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients
LVO AIS with COVID-19 n = 3 | LVO AIS without COVID-19 n = 4 | AMI N = 1 | Normal range | |
|---|---|---|---|---|
PLT count, × 103/μL | 633 | 150–450 | ||
(n. of pts with available data) | (3/3) | (4/4) | ||
Mean | 199.33 | 231.0 | ||
Median | 184.0 | 228.0 | ||
MPV, fL | 8.0 | 7.2–13.0 | ||
(n. of pts with available data) | (3/3) | (4/4) | ||
Mean | 9.5 | 8.1 | ||
Median | 9.5 | 8.2 | ||
INR | 1.31 | 0.8–1.2 | ||
(n. of pts with available data) | (3/3) | (2/4) | ||
Mean | 1.01 | 1.0 | ||
Median | 0.95 | 1.0 | ||
aPTT | 0.83 | 0.8–1.2 | ||
(n. of pts with available data) | (3/3) | (2/4) | ||
Mean | 0.89 | 0.94 | ||
Median | 0.96 | 0.92 | ||
d-dimer, μg/L | n/a | 390 | 0–550 | |
(n. of pts with available data) | (3/4) | |||
Mean | 1646.33 | |||
Median | 805.0 | |||
Fibrinogen, μg/dL | 277 | 200–400 | ||
(n. of pts with available data) | (3/3) | (3/4) | ||
Mean | 476.33 | 345.33 | ||
Median | 556.00 | 334.0 | ||
ATIII, % | n/a | n/a | 94 | 80–120 |
(n. of pts with available data) | ||||
Mean | ||||
Median | ||||
FVIII, % | n/a | 58–130 | ||
(n. of pts with available data) | (1/3) | (3/4) | ||
Mean | 83.30 | 55.97 | ||
Median | 54.90 | |||
vWFAg, % | n/a | 41–130 | ||
(n. of pts with available data) | (1/3) | (3/4) | ||
Mean | 221.90 | 136.33 | ||
Median | 138.0 | |||
vWFRCo, % | n/a | 41–124 | ||
(n. of pts with available data) | (1/3) | (3/4) | ||
Mean | 261.60 | 127.67 | ||
Median | 140.90 | |||
FXIII, % | n/a | 64–140 | ||
(n. of pts with available data) | (1/3) | (3/4) | ||
Mean | 107.80 | 83.10 | ||
Median | 82.50 |